{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:03:48Z","timestamp":1781870628671,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2010,10,16]],"date-time":"2010-10-16T00:00:00Z","timestamp":1287187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s00406-010-0153-7","type":"journal-article","created":{"date-parts":[[2010,10,15]],"date-time":"2010-10-15T05:50:30Z","timestamp":1287121830000},"page":"116-120","source":"Crossref","is-referenced-by-count":65,"title":["Individualised treatment in alcohol-dependent patients"],"prefix":"10.1007","volume":"260","author":[{"given":"Karl","family":"Mann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derik","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,16]]},"reference":[{"key":"153_CR1","volume-title":"Broadening the base of treatment for alcohol problems","author":"Institute of Medicine","year":"1990","unstructured":"Institute of Medicine (1990) Broadening the base of treatment for alcohol problems. National Academy Press, Washington"},{"key":"153_CR2","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1530-0277.1993.tb05219.x","volume":"17","author":"Project MATCH Research Group","year":"1993","unstructured":"Project MATCH Research Group (1993) Project match (matching alcoholism treatment to client heterogeneity): rationale and methods for a multisite clinical trial matching patients to alcoholism treatment. Alcohol Clin Exp Res 17:1130\u20131145","journal-title":"Alcohol Clin Exp Res"},{"key":"153_CR3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.15288\/jsa.1998.59.631","volume":"59","author":"Project MATCH Research Group","year":"1998","unstructured":"Project MATCH Research Group (1998) Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. J Stud Alcohol 59:631\u2013639","journal-title":"J Stud Alcohol"},{"key":"153_CR4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/alcalc\/36.1.11","volume":"36","author":"UKATT Research Team","year":"2001","unstructured":"UKATT Research Team (2001) United Kingdom alcohol treatment trial (UKATT): hypotheses, design and methods. Alcohol Alcohol 36:11\u201321","journal-title":"Alcohol Alcohol"},{"key":"153_CR5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0306-4603(01)00176-9","volume":"27","author":"A Copello","year":"2002","unstructured":"Copello A, Orfor J, Hodgson R, Tober G, Barrett C, UKATT Research Team (2002) United Kingdom alcohol treatment trial. Social behaviour and network therapy basic principles and early experiences. Addict Behav 27:345\u2013366","journal-title":"Addict Behav"},{"key":"153_CR6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/bmj.331.7516.541","volume":"331","author":"UKATT Research Team","year":"2005","unstructured":"UKATT Research Team (2005) Effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT). BMJ 331:541","journal-title":"BMJ"},{"key":"153_CR7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1360-0443.2007.02060.x","volume":"103","author":"UKATT Research Team","year":"2008","unstructured":"UKATT Research Team (2008) UK alcohol treatment trial: client-treatment matching effects. Addiction 103:228\u2013238","journal-title":"Addiction"},{"key":"153_CR8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/bmj.331.7516.544","volume":"331","author":"UKATT Research Team","year":"2005","unstructured":"UKATT Research Team (2005) Cost effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT). BMJ 331:544","journal-title":"BMJ"},{"key":"153_CR9","doi-asserted-by":"crossref","unstructured":"Vollst\u00e4dt-Klein S, Loeber S, Kirsch M, Richter A, B\u00fchler M, von der Goltz C, Hermann D, Mann K, Kiefer F (2010) Effects of cue-exposure treatment on neural cue-reactivity in alcohol-dependence: a randomized trial. Biol Psych (in press)","DOI":"10.1016\/j.biopsych.2010.12.016"},{"key":"153_CR10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/01.ALC.0000108656.81563.05","volume":"28","author":"K Mann","year":"2004","unstructured":"Mann K, Lehert P, Morgan MY (2004) The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcohol Clin Exp Res 28:51\u201363","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"153_CR11","first-page":"CD001867","volume":"25","author":"M Srisurapanont","year":"2005","unstructured":"Srisurapanont M, Jarusuraisin N (2005) Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev 25(1):CD001867","journal-title":"Cochrane Database Syst Rev"},{"key":"153_CR12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2174\/1874473710801030280","volume":"1","author":"M Soyka","year":"2008","unstructured":"Soyka M, R\u00f6sner S (2008) Opioid antagonists for pharmacological treatment of alcohol dependence\u2014a critical review. Curr Drug Abuse Rev 1:280\u2013291","journal-title":"Curr Drug Abuse Rev"},{"key":"153_CR13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archpsyc.60.1.92","volume":"60","author":"F Kiefer","year":"2003","unstructured":"Kiefer F, Jahn H, Tarnaske T, Helwig H, Briken P, Holzbach R, Kampf P, Stracke R, Baehr M, Naber D, Wiedemann K (2003) Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry 60:92\u201399","journal-title":"Arch Gen Psychiatry"},{"key":"153_CR14","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","volume":"295","author":"RF Anton","year":"2006","unstructured":"Anton RF, O\u2019Malley SS, COMBINE Study Research Group et al (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295:2003\u20132017","journal-title":"JAMA"},{"key":"153_CR15","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","volume":"95","author":"C Bond","year":"1998","unstructured":"Bond C, LaForge KS, Tian M et al (1998) Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 95:9608\u20139613","journal-title":"Proc Natl Acad Sci USA"},{"key":"153_CR16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugalcdep.2009.12.016","volume":"108","author":"SD Mague","year":"2010","unstructured":"Mague SD, Blendy JA (2010) OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. Drug Alcohol Depend 108:172\u2013182","journal-title":"Drug Alcohol Depend"},{"key":"153_CR17","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/sj.npp.1300219","volume":"28","author":"DW Oslin","year":"2003","unstructured":"Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O\u2019Brien CP (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28:1546\u20131552","journal-title":"Neuropsychopharmacology"},{"key":"153_CR18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archpsyc.65.2.135","volume":"65","author":"RF Anton","year":"2008","unstructured":"Anton RF, Oroszi G, O\u2019Malley S, Couper D, Swift R, Pettinati H, Goldman D (2008) An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the combined pharmacotherapies and behavioral interventions for alcohol dependence (COMBINE) study. Arch Gen Psychiatry 65:135\u2013144","journal-title":"Arch Gen Psychiatry"},{"key":"153_CR19","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archgenpsychiatry.2009.83","volume":"66","author":"J Treutlein","year":"2009","unstructured":"Treutlein J, Cichon S, Ridinger M et al (2009) Genome-wide association study of alcohol dependence. Arch Gen Psychiatry 66:773\u2013784","journal-title":"Arch Gen Psychiatry"},{"key":"153_CR20","doi-asserted-by":"crossref","unstructured":"Kiefer F, Witt SH, Frank J, Richter A, Treutlein J, Lemenager T et al. (2010) Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate. Pharmacogenomics J. 2010 (in Press)","DOI":"10.1038\/tpj.2010.51"},{"key":"153_CR21","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1530-0277.2008.00884.x","volume":"33","author":"K Mann","year":"2009","unstructured":"Mann K, Kiefer F, Smolka M, Gann H, Wellek S, Heinz A, PREDICT Study Research Team (2009) Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study. Alcohol Clin Exp Res 33:674\u2013683","journal-title":"Alcohol Clin Exp Res"},{"key":"153_CR22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0376-8716(96)01241-0","volume":"41","author":"A Victorio-Estrada","year":"1996","unstructured":"Victorio-Estrada A, Mucha RF, Stephan ER (1996) Excessive drinking situations in German alcoholics: replication of a three-factor model used for North Americans. Drug Alcohol Depend 41:75\u201379","journal-title":"Drug Alcohol Depend"},{"key":"153_CR23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.ALC.0000057122.36127.C2","volume":"27","author":"GF Koob","year":"2003","unstructured":"Koob GF (2003) Alcoholism: allostasis and beyond. Alcohol Clin Exp Res 27:232\u2013243","journal-title":"Alcohol Clin Exp Res"},{"key":"153_CR24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0166-2236(99)01447-2","volume":"22","author":"R Spanagel","year":"1999","unstructured":"Spanagel R, Weiss F (1999) The dopamine hypothesis of reward: past and current status. Trends Neurosci 22:521\u2013527","journal-title":"Trends Neurosci"},{"key":"153_CR25","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1360-0443.1995.tb01088.x","volume":"90","author":"J Littleton","year":"1995","unstructured":"Littleton J (1995) Acamprosate in alcohol dependence: how does it work? Addiction 90:1179\u20131188","journal-title":"Addiction"},{"key":"153_CR26","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1530-0277.2008.00690.x","volume":"32","author":"K Mann","year":"2008","unstructured":"Mann K, Kiefer F, Spanagel R, Littleton J (2008) Acamprosate: recent findings and future research directions. Alcohol Clin Exp Res 32:1105\u20131110","journal-title":"Alcohol Clin Exp Res"},{"key":"153_CR27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.psych.59.103006.093548","volume":"59","author":"GF Koob","year":"2008","unstructured":"Koob GF, Le Moal M (2008) Addiction and the brain antireward system. Annu Rev Psychol 59:29\u201353","journal-title":"Annu Rev Psychol"},{"key":"153_CR28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev.med.49.1.173","volume":"49","author":"G Tsai","year":"1998","unstructured":"Tsai G, Coyle JT (1998) The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med 49:173\u2013184","journal-title":"Annu Rev Med"},{"key":"153_CR29","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bcp.2007.06.039","volume":"75","author":"JT Gass","year":"2008","unstructured":"Gass JT, Olive MF (2008) Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol 75:218\u2013265","journal-title":"Biochem Pharmacol"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-010-0153-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-010-0153-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-010-0153-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T10:24:02Z","timestamp":1559730242000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-010-0153-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,16]]},"references-count":29,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["153"],"URL":"https:\/\/doi.org\/10.1007\/s00406-010-0153-7","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,16]]}}}